Jim,
Like most things, there is some truth interwoven among your comments. However, as far as WF10 goes, the study seems to have ended over 2 years ago, and still today we have no PIII results. That is just NOT acceptable.
As far as her raise goes and what is "average", and her not getting a raise for a few years -- that's the real world. I went for a 10-year period (not even the COL) without a raise and when I finally got one it was the COL from the previous year -- 3%. Would living on 250,000 for another year or two have killed her. Hell -- if Pennsaid gets approved in the US and if the WF10 results are ever published, she can have 3 million a year, for all I care.
So, for retail investors like me, and DMX has historically been a retail "average person's stock" a 50,000 dollar raise, at a time when my investment has tanked, does not sit well. The optics are bad to say the least.
I have been a supporter of REK for many years, but being a CEO is about judgement -- and what I saw there was not good judgement -- and I have to ask myself how much of that type of judgement has pervaded other DMX issues/decisions.
Have a good day.
MB |
